Yarchoan; Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yarchoan; Robert.The latest application filed is for "methods for the treatment of kaposi's sarcoma or kshv-induced lymphoma using immunomodulatory compounds, and uses of biomarkers".

Company Profile

1.10.3

Yarchoan; Robert - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Grant 10,001,483 - Yarchoan , et al. June 19, 2	2018-06-19
Methods For The Treatment Of Kaposi's Sarcoma Or Kshv-induced Lymphoma Using Immunomodulatory Compounds, And Uses Of Biomarkers App 20160377621 - YARCHOAN; Robert ; et al.	2016-12-29
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus Grant 9,474,793 - Catanzaro , et al. October 25, 2	2016-10-25
Vaccines And Methods For Prevention And Treatment Of Drug-resistant Hiv-1 And Hepatitis B Virus App 20090317418 - Catanzaro; Andrew ; et al.	2009-12-24
Treatment of Kaposi's sarcoma with IL-12 App 20030190305 - Yarchoan, Robert ; et al.	2003-10-09
Treatment of Kaposi's sarcoma with IL-12 Grant 6,509,321 - Yarchoan , et al. January 21, 2	2003-01-21
Treatment of Kaposi's sarcoma with IL-12 Grant 6,423,308 - Yarchoan , et al. July 23, 2	2002-07-23
Methods of inhibiting viral replication using IL-10 Grant 5,665,345 - Yarchoan , et al. September 9, 1	1997-09-09
Method of inhibiting HIV replication with 2',3'-dideoxyadenosine Grant 5,616,566 - Mitsuya , et al. April 1, 1	1997-04-01
Treatment of retroviral induced dementia by administration of 2',3'-dideoxyinosine Grant 5,376,642 - Yarchoan , et al. December 27, 1	1994-12-27
Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds Grant 5,026,687 - Yarchoan , et al. June 25, 1	1991-06-25
Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same Grant 4,707,443 - Nelson , et al. November 17, 1	1987-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.